Literature DB >> 20972812

The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.

Nunzia Montuori1, Katia Bifulco, Maria Vincenza Carriero, Claudio La Penna, Valeria Visconte, Daniela Alfano, Ada Pesapane, Francesca Wanda Rossi, Salvatore Salzano, Guido Rossi, Pia Ragno.   

Abstract

The receptor (CXCR4) for the stromal-derived factor-1 (SDF1) and the urokinase-receptor (uPAR) are up-regulated in various tumors. We show that CXCR4-transfected cells migrate toward SDF1 on collagen (CG) and do not on vitronectin (VN). Co-expression of cell-surface uPAR, which is a VN receptor, impairs SDF1-induced migration on CG and allows migration on VN. Blocking fMLP receptors (fMLP-R), alpha-v integrins or the uPAR region capable to interact with fMLP-Rs, impairs migration of uPAR/CXCR4-transfected cells on VN and restores their migration on CG. uPAR co-expression also reduces the adherence of CXCR4-expressing cells to various components of the extracellular matrix (ECM) and influences the partitioning of beta1 and alpha-v integrins to membrane lipid-rafts, affecting ECM-dependent signaling. uPAR interference in CXCR4 activity has been confirmed in cells from prostate carcinoma. Our results demonstrate that uPAR expression regulates the adhesive and migratory ability of CXCR4-expressing cells through a mechanism involving fMLP receptors and alpha-v integrins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20972812     DOI: 10.1007/s00018-010-0564-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  56 in total

Review 1.  The plasminogen activator system: biology and regulation.

Authors:  J P Irigoyen; P Muñoz-Cánoves; L Montero; M Koziczak; Y Nagamine
Journal:  Cell Mol Life Sci       Date:  1999-10-01       Impact factor: 9.261

Review 2.  Vitronectin receptor alpha(V)beta(3) integrin antagonists: chemical and structural requirements for activity and selectivity.

Authors:  Christophe Henry; Nicolas Moitessier; Yves Chapleur
Journal:  Mini Rev Med Chem       Date:  2002-12       Impact factor: 3.862

Review 3.  Tether and trap: regulation of membrane-raft dynamics by actin-binding proteins.

Authors:  Antonella Viola; Neetu Gupta
Journal:  Nat Rev Immunol       Date:  2007-11       Impact factor: 53.106

4.  Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor.

Authors:  Bernard Degryse; Massimo Resnati; Ralf-Peter Czekay; David J Loskutoff; Francesco Blasi
Journal:  J Biol Chem       Date:  2005-04-29       Impact factor: 5.157

5.  Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization.

Authors:  Carmine Selleri; Nunzia Montuori; Patrizia Ricci; Valeria Visconte; Maria Vincenza Carriero; Nicolai Sidenius; Bianca Serio; Francesco Blasi; Bruno Rotoli; Guido Rossi; Pia Ragno
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

6.  The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1.

Authors:  B Q Li; M A Wetzel; J A Mikovits; E E Henderson; T J Rogers; W Gong; Y Le; F W Ruscetti; J M Wang
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

Review 7.  The significance of cancer cell expression of the chemokine receptor CXCR4.

Authors:  Fran Balkwill
Journal:  Semin Cancer Biol       Date:  2004-06       Impact factor: 15.707

Review 8.  G-protein coupled chemoattractant receptors and cancer.

Authors:  Jian Huang; Keqiang Chen; Wanghua Gong; Nancy M Dunlop; Ji Ming Wang
Journal:  Front Biosci       Date:  2008-05-01

9.  Real-time analysis of conformation-sensitive antibody binding provides new insights into integrin conformational regulation.

Authors:  Alexandre Chigaev; Anna Waller; Or Amit; Liliana Halip; Cristian G Bologa; Larry A Sklar
Journal:  J Biol Chem       Date:  2009-02-27       Impact factor: 5.157

10.  uPAR-induced cell adhesion and migration: vitronectin provides the key.

Authors:  Chris D Madsen; Gian Maria Sarra Ferraris; Annapaola Andolfo; Orla Cunningham; Nicolai Sidenius
Journal:  J Cell Biol       Date:  2007-06-04       Impact factor: 10.539

View more
  17 in total

Review 1.  Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells.

Authors:  Xiao-hong Yao; Ying Liu; Keqiang Chen; Wanghua Gong; Ming-yong Liu; Xiu-wu Bian; Ji Ming Wang
Journal:  Int Immunopharmacol       Date:  2011-09-17       Impact factor: 4.932

2.  Co-expression of uPAR and CXCR4 promotes tumor growth and metastasis in small cell lung cancer.

Authors:  Yanlei Li; Yao Shen; Yajing Miao; Yajing Luan; Baocun Sun; Xiaofei Qiu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 3.  Chemokines and their receptors in lung cancer progression and metastasis.

Authors:  Zeng-Hui Cheng; Yu-Xin Shi; Min Yuan; Dan Xiong; Jiang-Hua Zheng; Zhi-Yong Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2016-05       Impact factor: 3.066

4.  CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines.

Authors:  Alessio Biagioni; Anastasia Chillà; Mario Del Rosso; Gabriella Fibbi; Francesca Scavone; Elena Andreucci; Silvia Peppicelli; Francesca Bianchini; Lido Calorini; Anna Li Santi; Pia Ragno; Francesca Margheri; Anna Laurenzana
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

5.  Involvement of the soluble urokinase receptor in chondrosarcoma cell mobilization.

Authors:  Katia Bifulco; Immacolata Longanesi-Cattani; Maria Teresa Masucci; Annarosaria De Chiara; Flavio Fazioli; Gioconda Di Carluccio; Giuseppe Pirozzi; Michele Gallo; Antonello La Rocca; Gaetano Apice; Gaetano Rocco; Maria Vincenza Carriero
Journal:  Sarcoma       Date:  2010-12-30

6.  Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes.

Authors:  Ali Munaim Yousif; Michele Minopoli; Katia Bifulco; Vincenzo Ingangi; Gioconda Di Carluccio; Francesco Merlino; Maria Letizia Motti; Paolo Grieco; Maria Vincenza Carriero
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

7.  Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells.

Authors:  Daniela Alfano; Anna Gorrasi; Anna Li Santi; Patrizia Ricci; Nunzia Montuori; Carmine Selleri; Pia Ragno
Journal:  J Cell Mol Med       Date:  2015-06-16       Impact factor: 5.310

8.  Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer.

Authors:  Nunzia Montuori; Ada Pesapane; Francesca W Rossi; Valentina Giudice; Amato De Paulis; Carmine Selleri; Pia Ragno
Journal:  Transl Med UniSa       Date:  2016-11-01

9.  Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion.

Authors:  Katia Bifulco; Immacolata Longanesi-Cattani; Paola Franco; Vincenzo Pavone; Pietro Mugione; Gioconda Di Carluccio; Maria Teresa Masucci; Claudio Arra; Giuseppe Pirozzi; Maria Patrizia Stoppelli; Maria Vincenza Carriero
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

10.  The urokinase receptor takes control of cell migration by recruiting integrins and FPR1 on the cell surface.

Authors:  Anna Gorrasi; Anna Li Santi; Giuseppina Amodio; Daniela Alfano; Paolo Remondelli; Nunzia Montuori; Pia Ragno
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.